NOX enzymes also play an important role in oncology, particularly in potential resistance to anti-cancer treatments due to the presence of a fibrotic stroma around tumors, as well as in certain diseases of the central nervous system, such as Parkinson's disease. Genkyotex therefore continues to seek non-dilutive financing opportunities to support the preclinical development of product candidates in these therapeutic areas.